v3.26.1
STOCK-BASED COMPENSATION (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of stock option and restricted stock activity
A summary of stock options (including Inducement Grants), RSA, RSU, and PSU activity under the Amended 2022 Stock Plan and Inducement Grants during the six months ended June 30, 2026 is presented below:
(in thousands)OptionsPSUsRSAsRSUs
Outstanding/Unvested at December 31, 20253512301,53722
Granted—14562421
Options Exercised/PSUs, RSAs, and RSUs Vested(19)(159)(545)
(1)
(5)
Forfeited——(79)—
Outstanding/Unvested at June 30, 20263322161,53738
_____________________________________________
(1)Includes 271,000 shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $20.6 million total purchase price for the shares is included in Treasury stock in the accompanying unaudited condensed consolidated balance sheets.
Summary of allocated expense
The following table summarizes stock-based compensation expense incurred for ESPP expense, stock options, restricted stock awards, restricted stock units, performance-based restricted stock units, and Inducement Grants included in the accompanying unaudited condensed consolidated statements of operations:
Three Months Ended June 30,Six Months Ended June 30,
(in thousands)2026202520262025
Cost of sales$552 $405 $1,047 $780 
Research and development616 583 1,240 1,109 
Selling, general, and administrative10,238 8,615 19,310 16,581 
Total$11,406 $9,603 $21,597 $18,470